Table 3.
Group | p | ||||
---|---|---|---|---|---|
Covid-19 | Controls | ||||
Mean | SD | Mean | SD | ||
LVEF | 59.22 | 3.72 | 60.14 | 3.20 | 0.187 |
LVGLS | 18.47 | 2.40 | 21.07 | 1.76 | < 0.001 |
LATLS | 17.77 | 3.49 | 20.97 | 2.86 | < 0.001 |
POSTLS | 19.52 | 5.30 | 22.23 | 2.65 | 0.020 |
RVGLS | 21.29 | 5.88 | 26.04 | 4.55 | < 0.001 |
IVSLS | 20.11 | 3.58 | 20.12 | 2.62 | 0.988 |
ANTLS | 20.70 | 2.19 | 21.60 | 2.84 | 0.437 |
INFLS | 20.58 | 4.11 | 21.76 | 2.56 | 0.192 |
All analyses were performed adjusting for the effect of hypertension, hyperlipidemia and DM. LVEF left ventricular ejection fraction, LVGLS left ventricular global longitudinal strain, LATLS longitudinal strain of lateral wall, POSTLS longitudinal strain of posterior wall, RVGLS right ventricular global longitudinal strain, IVSLS longitudinal strain of interventricular septum, ANTLS longitudinal strain of anterior wall, INFLS longitudinal strain of inferior wall